Searchable abstracts of presentations at key conferences in endocrinology

ea0038p4 | Bone | SFEBES2015

Mutations in G-protein subunit αq (GNAQ) are not a cause of familial hypocalciuric hypercalcaemia

Modi Manish , Cranston Treena , Rogers Angela , Howles Sarah , Gorvin Caroline , Thakker Rajesh

Familial hypocalciuric hypercalcaemia (FHH) is an autosomal dominant disorder characterised by hypercalcaemia and inappropriately low renal calcium excretion. FHH can be classified into three types: FHH1, caused by calcium-sensing receptor (CaSR) loss-of-function mutations, accounting for >65% of cases; FHH2, due to loss-of-function mutations of the G-protein α11 subunit (Gα11); and FHH3, resulting from loss-of-function mutations in the adap...

ea0038p146 | Neoplasia, cancer and late effects | SFEBES2015

The somatostatin analogue pasireotide decreased proliferation and increased apoptosis in pancreatic and pituitary neuroendocrine tumors in a MEN1 mouse model

Stevenson Mark , Walls Gerard , Soukup Ben , Lines Kate , Grossman Ashley , Schmid Herbert , Thakker Rajesh

Improved therapies for pancreatic and pituitary neuroendocrine tumors (NETs), which may occur in Multiple Endocrine Neoplasia type 1 (MEN1), are needed. We assessed the effects of pasireotide, a somatostatin analogue with high affinity for somatostatin receptors (SSTRs) −1, −2, −3 and −5, in a mouse model of MEN1. Men1+/− mice treated from 12 months of age with 40 μg/g pasireotide (n=71), or phosphate-buffered sal...

ea0038p302 | Pituitary | SFEBES2015

Menin regulates the expression of miR-15a, which is downregulated and inversely correlates with cyclin D1 expression in mouse Men1-associated pituitary tumours

Lines Kate E , Newey Paul J , Yates Chris J , Walls Gerard V , Thakker Rajesh V

Multiple Endocrine Neoplasia type 1 (MEN1) is an autosomal dominant disorder characterised by the combined occurrence of parathyroid, pituitary and pancreatic islet tumours, and is due to mutations of the MEN1 gene, which encodes the tumour suppressor protein menin. MicroRNAs (miRNA) are non-coding single stranded RNAs that post-transcriptionally regulate gene expression. Alterations in miRNA expression, including downregulation of two miRNAs, miR-15a and miR-16-1, have been r...

ea0037ep1027 | Thyroid (non-cancer) | ECE2015

Association between thyroid specific genotypic variation and phenotypic expression of dyshormogenetic goitre and Hashimoto's thyroiditis in children and adolescents: a South Indian experience

Ramesh B , Aparna Verma B , Vijayaraghavan R , Ramakanth Bhargav P , Rajesh B

Background: Thyroid disorders are the commonest endocrine disorder after diabetes in most of the populations worldwide. Though, hypothyroidism is extremely common in children, there is acute scarcity of genetic studies leading to improper screening and treatment protocols in developing countries. The aim of this ambitious study was to screen for NIS, DUOX2 and TPO mutations in south Indian children and adolescent patients with dyshormogenetic goiter (DH) and Hashimoto’s t...

ea0034oc4.1 | Thyroid and bone | SFEBES2014

Adaptor protein-2 sigma subunit mutations causing familial hypocalciuric hypercalcaemia type 3 exert dominant-negative effects

Howles Sarah , Nesbit M Andrew , Hannan Fadil , Rogers Angela , Piret Sian , Rust Nigel , Thakker Rajesh

Adaptor protein-2 (AP2) is a heterotetramer of α, β, μ, and σ subunits that is pivotal in clathrin-mediated endocytosis and facilitates internalisation of plasma membrane constituents such as the calcium-sensing receptor (CaSR). AP2 σ subunit (AP2σ) missense mutations (Arg15Cys, Arg15His and Arg15Leu) result in familial hypocalciuric hypercalcaemia type 3 (FHH3) and decrease the sensitivity of CaSR-expressing cells to changes in extracellular calc...

ea0034oc4.5 | Thyroid and bone | SFEBES2014

A mutation in the 5′-UTR of GNA11 causes familial hypocalciuric hypercalcemia type 2 due to reduced translational efficiency

Howles Sarah , Nesbit MAndrew , Hannan Fadil , Piret Sian , Cranston Treena , Rahman Mushtaqur , Thakker Rajesh

The calcium-sensing receptor (CaSR) is a guanine-nucleotide-binding protein (G-protein)-coupled receptor that has a central role in calcium homeostasis. Loss-of-function mutations of the CaSR result in familial hypocalciuric hypercalcemia type 1 (FHH1) and loss-of-function coding mutations in the CaSR-associated G-protein subunit Gα11 have been reported to cause FHH2 in only two patients to date. The aim of our study was therefore to characterise additional <em...

ea0034p17 | Bone | SFEBES2014

The calcilytic NPS2143 rectifies the gain-of-function associated with G-protein α 11 mutations causing autosomal dominant hypocalcaemia type 2

Babinsky Valerie , Hannan Fadil , Nesbit M Andrew , Howles Sarah , Hu Jianxin , Spiegel Allen , Thakker Rajesh

Autosomal dominant hypocalcaemia (ADH) is a disorder that needs to be distinguished from hypoparathyroidism, as ADH patients are at risk of nephrocalcinosis and renal failure when treated with activated vitamin D preparations. ADH types 1 and 2 are due to gain-of-function mutations of the calcium-sensing receptor (CaSR) and G-protein α 11 (Gα11), respectively. CaSR targeted drugs, known as calcilytics, rectify the gain-of-function associated with ADH1-causing mutatio...

ea0070aep555 | General Endocrinology | ECE2020

Invivo endocrine internet: An unique model of endocrine system

Bhargav Panchangam Ramakanth , Bangaraiahgari Ramesh , Mohammad Rafi , Mayilvaganan Sabaretnam , Bangaraiahgari Rajesh , Reddy Banala Rajkiran

Background: Endocrine system (ES) is unique amongst all organ systems (OS) in human body. ES is a conglomeration of different endocrine organs. So far, the only models of proof o fintegrity within ES are APUD cell concept; HPA axis; HPG axis; biochemical pathways of hormones. But, the flaws in the above models are their presumptive and extrapolative nature. We wanted to test a model that every endocrine disease has collateral effect on other endocrine organs. We took nontoxic ...

ea0070aep1052 | Hot topics (including COVID-19) | ECE2020

Characteristics and outcomes in COVID –19 with Type 2 diabetes as compared with patients without diabetes – Retrospective single center cohort study

Gosavi Rajesh , Mitra Sajal , Aher Archana , Holay Madhuri , Patil Somraj , Assudani Deepanshu

Introduction: COVID 19 is now a global pandemic. Diabetes is postulated to be a risk factor for mortality due to COVID –19Methods: We retrospectively evaluated the inpatient medical record data, of patients admitted over last two months in a public hospital in Central India to compare the attributes of mortality in patients without T2DM and with T2DM including their glycemic clinical characteristics. Unpaired t – test and Fisher’s exact...

ea0070ep158 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

Correlation between pro–inflammatory biomarkers and vitamin B12 levels in diabetes mellitus: A prospective study

Bangaraiahgari Ramesh , K Divya , Bhargav Panchangam Ramakanth , Bangaraiahgari Rajesh , reddy Banala Rajkiran

Introduction: Apart from genetics, autoimmunity has been implicated in pathogenesis of diabetes mellitus (DM). Further the role of vitamin B12 levels in diabetic immunomodulation is controversial. In this context, we set out study the role of Pro– inflammatory cytokines in DM with or without vitamin B 12 deficiency in South Indian population.Material and Methods: This prospective case–control study was conducted on diabetes mellitus patients....